Digitoxin is a cardiac glycoside used for the treatment of heart failure and certain kinds of heart arrhythmia. It is a phytosteroid and is similar in structure and effects to digoxin, though the effects are …

Dec 9, 2025 · "Based on our findings, digitoxin represents an additional option for patients with HFrEF, particularly those with atrial fibrillation, higher heart rates, low blood pressure or impaired kidney …

1 day ago · Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure POLY-HF, FRESH-UP, and FOOD-HF also caught experts’ attention this year, as did longer-term data from …

Aug 29, 2025 · Digitoxin reduced the risk of a composite of all-cause death and hospital admission for worsening heart failure, suggesting digitoxin may represent an additional treatment to current …

Digitoxin is a cardiac glycoside used in the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.

Aug 29, 2025 · Treatment with digitoxin led to a lower combined risk of death from any cause or hospital admission for worsening heart failure than placebo among patients with heart failure and reduced …

Aug 30, 2025 · A LATE-breaking ESC 2025 trial has demonstrated that digitoxin, an old cardiac glycoside, significantly reduces the risk of all-cause death and hospitalisation for worsening heart …

Digitoxin is a lipid-soluble cardiac glycoside that is used to treat congestive heart failure, arrhythmias, and heart failure. It works by blocking the sodium-potassium ATPase in the plasma membrane, …

Jun 30, 2025 · DIGIT-HF is a randomized, double-blind, parallel-group, placebo-controlled, two-arm, multicentre, event-driven phase IV trial evaluating the efficacy and safety of digitoxin compared to …

Aug 29, 2025 · Digitoxin, a generic cardiac glycoside, appeared to be safe. In patients with heart failure with reduced ejection fraction on guideline-directed medical therapy, digitoxin conferred lower rates...